TickerFacts.

Fate Therapeutics Inc (FATE): Long-Term Debt

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Long-Term Debt is for the year ended 2018-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$18.48M
As of 2018-12-31
-5.0%
3-year compound annual growth
+60.2%
5-year compound annual growth
$21.57M2012-12-31: $3.73M2013-12-31: $1.75M2014-12-31: $19.63M2015-12-31: $21.57M2016-12-31: $12.81M2017-12-31: $19.32M2018-12-31: $18.48M$18.48M
2012-12-31 Long-Term Debt (USD) 2018-12-31
Period endedLong-Term DebtChange YoYSource filing
2018-12-31$18.48M-4.3%2019-03-05, Balance as of period end
2017-12-31$19.32M+50.8%2018-03-05, Balance as of period end
2016-12-31$12.81M-40.6%2017-03-16, Balance as of period end
2015-12-31$21.57M+9.9%2016-03-03, Balance as of period end
2014-12-31$19.63Mn/m2015-03-12, Balance as of period end
2013-12-31$1.75M-53.1%2015-03-12, Balance as of period end
2012-12-31$3.73Mn/a2014-03-17, Balance as of period end